RPN2 and gastric adenocarcinoma: RPN2, as a hopeful prognostic indicator in human gastric adenocarcinoma, is a valid biomarker to forecast the consequence of chemotherapy for terminal gastric cancer,29 Zhang et al30 reported that DDOST was one of the core genes involved in bladder cancer.